Discontinuation report PMS-CELECOXIB
Report ID | 166948 |
Drug Identification Number | 02355450 |
Brand name | PMS-CELECOXIB |
Common or Proper name | CELECOXIB |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 200MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-08-16 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Please note that this now available under: pmsc-Celecoxib 200mg |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-08-18 | French | Compare |
v1 | 2022-08-18 | English | Compare |
Showing 1 to 2 of 2